HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Return
11.46%
This Quarter Return
+13.7%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.37B
AUM Growth
-$351M
(-13%)
Cap. Flow
-$536M
Cap. Flow
% of AUM
-22.65%
Top 10 Holdings %
Top 10 Hldgs %
50.33%
Holding
61
New
23
Increased
10
Reduced
11
Closed
14
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$105M |
| 2 |
AGN
Allergan plc
AGN
|
$90.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
$65.9M |
| 4 |
Icon
ICLR
|
$55.8M |
| 5 |
UnitedHealth
UNH
|
$54.2M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$165M |
| 2 |
CVS Health
CVS
|
$153M |
| 3 |
Intuitive Surgical
ISRG
|
$144M |
| 4 |
LivaNova
LIVN
|
$139M |
| 5 |
CELG
Celgene Corp
CELG
|
$125M |
Sector Composition
| 1 | Healthcare | 91.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WMGI
26
DELISTED
Wright Medical Group Inc
WMGI
| $37.3M | 1.51% |
+1,186,830
| New | +$37.3M |
|
|
CVRS
27
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $34.8M | 1.4% |
19,981,655
| – | – |
|
|
CLVS
28
DELISTED
Clovis Oncology, Inc.
CLVS
| $34.7M | 1.4% |
+1,398,300
| New | +$34.7M |
|
|
VRAY
29
DELISTED
ViewRay, Inc.
VRAY
| $31M | 1.25% |
4,192,550
-311,080
| -7% | -$2.3M |
|
30
CONMED
CNMD
$1.7B
| $28.2M | 1.14% |
+339,500
| New | +$28.2M |
|
31
Pacira BioSciences
PCRX
$1.19B
| $26.9M | 1.09% |
706,379
-1,791,749
| -72% | -$68.2M |
|
|
MDCO
32
DELISTED
Medicines Co
MDCO
| $20.8M | 0.84% |
745,910
-2,125,373
| -74% | -$59.4M |
|
33
HCA Healthcare
HCA
$98.5B
| $19.1M | 0.77% |
+146,810
| New | +$19.1M |
|
|
NVRO
34
DELISTED
NEVRO CORP.
NVRO
| $16.1M | 0.65% |
256,990
+101,580
| +65% | +$6.35M |
|
35
iRhythm Technologies
IRTC
$5.82B
| $15.9M | 0.64% |
+211,630
| New | +$15.9M |
|
36
Iovance Biotherapeutics
IOVA
$901M
| $11.4M | 0.46% |
+1,198,190
| New | +$11.4M |
|
37
Ironwood Pharmaceuticals
IRWD
$188M
| $10.1M | 0.41% |
+892,154
| New | +$10.1M |
|
38
Abbott
ABT
$231B
| $9.55M | 0.39% |
+119,470
| New | +$9.55M |
|
39
Select Medical
SEM
$1.62B
| $8.45M | 0.34% |
+1,113,600
| New | +$8.45M |
|
|
BHVN
40
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $7.83M | 0.32% |
+152,040
| New | +$7.83M |
|
|
GNFT
41
Genfit
GNFT
$197M
| $7.8M | 0.32% |
+325,000
| New | +$7.8M |
|
|
PTE
42
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $4.28M | 0.17% |
16,000
-12,852
| -45% | -$3.44M |
|
|
CBAY
43
DELISTED
Cymabay Therapeutics
CBAY
| $2.98M | 0.12% |
+224,640
| New | +$2.98M |
|
44
Precision BioSciences
DTIL
$59.8M
| $2.69M | 0.11% |
+5,000
| New | +$2.69M |
|
45
Karyopharm Therapeutics
KPTI
$57.2M
| $1.73M | 0.07% |
+19,742
| New | +$1.73M |
|
|
AMRN
46
Amarin Corp
AMRN
$317M
| – | – |
-152,304
| Closed | -$41.5M |
|
47
Amneal Pharmaceuticals
AMRX
$3.02B
| – | – |
-2,118,377
| Closed | -$28.7M |
|
48
Biogen
BIIB
$20.6B
| – | – |
-66,780
| Closed | -$20.1M |
|
49
Bristol-Myers Squibb
BMY
$96B
| – | – |
-294,490
| Closed | -$15.3M |
|
50
Cigna
CI
$81.5B
| – | – |
-584,390
| Closed | -$111M |
|